MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Delivering chemotherapy drugs in nanoparticle form could help reduce side effects by targeting the drugs directly to the tumors. In recent years, scientists have developed nanoparticles that deliver one or two chemotherapy drugs, but it has been difficult to design particles that can carry any more than that in a precise ratio.
Now MIT chemists have devised a new way to build such nanoparticles, making it much easier to include three or more different drugs. In a paper published in the Journal of the American Chemical Society, the researchers showed that they could load their particles with three drugs commonly used to treat ovarian cancer.
“We think it’s the first example of a nanoparticle that carries a precise ratio of three drugs and can release those drugs in response to three distinct triggering mechanisms,” says Jeremiah Johnson, an assistant professor of chemistry at MIT and the senior author of the new paper.
Such particles could be designed to carry even more drugs, allowing researchers to develop new treatment regimens that could better kill cancer cells while avoiding the side effects of traditional chemotherapy. In the JACS paper, Johnson and colleagues demonstrated that the triple-threat nanoparticles could kill ovarian cancer cells more effectively than particles carrying only one or two drugs, and they have begun testing the particles against tumors in animals.
Longyan Liao, a postdoc in Johnson’s lab, is the paper’s lead author.
Putting the pieces together
Johnson’s new approach overcomes the inherent limitations of the two methods most often used to produce drug-delivering nanoparticles: encapsulating small drug molecules inside the particles or chemically attaching them to the particle. With both of these techniques, the reactions required to assemble the particles become increasingly difficult with each new drug that is added.
Combining these two approaches — encapsulating one drug inside a particle and attaching a different one to the surface — has had some success, but is still limited to two drugs.
Johnson set out to create a new type of particle that would overcome those constraints, enabling the loading of any number of different drugs. Instead of building the particle and then attaching drug molecules, he created building blocks that already include the drug. These building blocks can be joined together in a very specific structure, and the researchers can precisely control how much of each drug is included.
Each building block consists of three components: the drug molecule, a linking unit that can connect to other blocks, and a chain of polyethylene glycol (PEG), which helps protect the particle from being broken down in the body. Hundreds of these blocks can be linked using an approach Johnson developed, called “brush first polymerization.”
“This is a new way to build the particles from the beginning,” Johnson says. “If I want a particle with five drugs, I just take the five building blocks I want and have those assemble into a particle. In principle, there’s no limitation on how many drugs you can add, and the ratio of drugs carried by the particles just depends on how they are mixed together in the beginning.”
For this paper, the researchers created particles that carry the drugs cisplatin, doxorubicin, and camptothecin, which are often used alone or in combination to treat ovarian cancer.
Each particle carries the three drugs in a specific ratio that matches the maximum tolerated dose of each drug, and each drug has its own release mechanism. Cisplatin is freed as soon as the particle enters a cell, as the bonds holding it to the particle break down on exposure to glutathione, an antioxidant present in cells. Camptothecin is also released quickly when it encounters cellular enzymes called esterases.
The third drug, doxorubicin, was designed so that it would be released only when ultraviolet light shines on the particle. Once all three drugs are released, all that is left behind is PEG, which is easily biodegradable.
This approach “represents a clever new breakthrough in multidrug release through the simultaneous inclusion of different drugs, through distinct chemistries, within the same … platform,” says Todd Emrick, a professor of polymer science and engineering at the University of Massachusetts at Amherst who was not involved in the study.
Working with researchers in the lab of Paula Hammond, the David H. Koch Professor of Engineering and a member of MIT’s Koch Institute for Integrative Cancer Research, the team tested the particles against ovarian cancer cells grown in the lab. Particles carrying all three drugs killed the cancer cells at a higher rate than those that delivered only one or two drugs.
Johnson’s lab is now working on particles that carry four drugs, and the researchers are also planning to tag the particles with molecules that will allow them to home to tumor cells by interacting with proteins found on the cell surfaces.
Johnson also envisions that the ability to reliably produce large quantities of multidrug-carrying nanoparticles will enable large-scale testing of possible new cancer treatments. “It’s important to be able to rapidly and efficiently make particles with different ratios of multiple drugs, so that you can test them for their activity,” he says. “We can’t just make one particle, we need to be able to make different ratios, which our method can easily do.”
The Latest on: Nanoparticle chemotherapy
via Google News
The Latest on: Nanoparticle chemotherapy
- Enhancing cancer immunotherapy with nanomedicineon January 31, 2020 at 5:49 am
Thus, this approach can also be used to enhance the delivery of drugs that are meant for other cells in the TME. For example, attachment of lipid nanoparticles carrying a potent but poorly soluble ...
- Simple, cheap nanoparticles activate immune system against canceron January 30, 2020 at 11:17 pm
In lab tests, the nanoparticles were able to cling to PD-L1 just as strongly as others, inhibiting the cancer’s ability to hide from T cells by about 50 percent. In other tests, this technique made ...
- New cancer treatment method could prove less costly, study showson January 30, 2020 at 7:38 pm
This new treatment was also shown to improve the effectiveness of a chemotherapy drug called doxorubicin in similar tests. According to the release, Hong has applied for a patent on the new ...
- New Nanoparticles Could Be Effective and More Affordable to Fight Canceron January 30, 2020 at 9:00 am
The effectiveness of the nanoparticles was on par with that of antibodies. They could also boost the effectiveness of doxorubicin, a chemotherapy drug, in similar tests. In general, T cells synthesize ...
- Sequential delivery of synergistic drugs by silica nanocarriers for enhanced tumour treatment.on January 30, 2020 at 8:11 am
Herein hybrid silica nanoparticles have been engineered to direct the sequential ... The cap, which is a derivative of 5-fluorouracil, serves as a second cytotoxic drug for synergistic chemotherapy.
- Nanoparticles could be an alternative to antibody immunotherapieson January 30, 2020 at 7:33 am
The nanoparticles were also able to improve the effectiveness of the chemotherapy drug doxorubicin in similar tests. The PD-1 protein is produced by T cells and acts as an ‘off switch’ for immune ...
- Cheap nanoparticles stimulate immune response to cancer in the labon January 29, 2020 at 8:05 am
They were just as effective as antibodies. The nanoparticles were also able to improve the effectiveness of the chemotherapy drug doxorubicin in similar tests. Normally, T cells produce a protein ...
- Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agenton January 28, 2020 at 2:17 am
Since the discovery of metal nanoparticles (NPs) in the 1960s, unknown toxicity ... Additionally, the Pt NPs are safe for use in humans and can act as anti-cancer agents to inhibit ...
- Can Phage-mimicking Antibacterial Core-shell Nanoparticles Help Tackle Antibiotic Resistance?on January 27, 2020 at 8:55 am
This is in order to prevent antibiotic treatments that are essential to cancer chemotherapy, pneumonia and tuberculosis therapies ... In their paper, the team demonstrates how created a ...
- Cancer: Using copper to boost immunotherapyon January 25, 2020 at 3:17 am
However, this does not always work or may only slow down the growth of cancer, so it cannot yet replace chemotherapy. In the new study on mice, the scientists combined immunotherapy with copper-based ...
via Bing News